Through reducing m6A abundance of ASB2 and RARA for destabilizing its transcripts, high FTO expression could enhance cell transformation and leukemogenesis, while it could inhibit all-trans-retinoic acid (ATRA)-induced AML cell differentiation (50). The gene discussed is FTO; the disease is acute myeloid leukemia.